{"entity":{"id":"norroy-bioscience","kind":"company","name":"Norroy Bioscience","aka":["Norroy Bioscience Co., LTD"],"tldr":"Norroy Bioscience is a China-based radiopharmaceutical company that leads 3 cancer trials in OnCo, testing the PSMA-targeted radiopharmaceuticals 177Lu-NYM032 and 68Ga-NYM032 in prostate cancer.","summary":"Norroy Bioscience is a clinical-stage company developing therapeutic and diagnostic radiopharmaceuticals together with automated synthesis systems for their manufacture. Its candidates are led by PSMA-targeted 177Lu-NYM032 and 68Ga-NYM032 in prostate cancer and CAIX-targeted tracers in kidney cancer. On ClinicalTrials.gov it is the lead sponsor of 3 trials recorded in OnCo (2 in phase 3 or 2/3): NCT06383052 (phase 1/2, A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC), NCT07615101 (phase 3, Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in...) and NCT07649122 (phase 3, This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imagin...). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-17","links":[{"label":"Official website","url":"https://www.norroybiopharm.com/"},{"label":"ClinicalTrials.gov: trials led by Norroy Bioscience","url":"https://clinicaltrials.gov/search?lead=Norroy%20Bioscience%20Co.%2C%20LTD"}],"tags":["ctgov-sponsor"],"related":[],"cancers":["prostate"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct06383052","nct07615101","nct07649122"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo orphan-trial linking round (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-17"},"hq":"Wuxi, Jiangsu","country":"CN","companyType":"radiopharma","website":"https://www.norroybiopharm.com/","founded":2021,"stage":"growth","investors":[],"funding":[]},"route":"/companies/norroy-bioscience/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"trial":[{"id":"nct06383052","kind":"trial","name":"A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC","route":"/trials/nct06383052/"},{"id":"nct07615101","kind":"trial","name":"Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.","route":"/trials/nct07615101/"},{"id":"nct07649122","kind":"trial","name":"This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.","route":"/trials/nct07649122/"}]}}